Virus News and Research

Latest Virus News and Research

Ten common notions concerning colds and flu

The cold and flu season has hit early and hard this year. As the number of people infected continues to increase, so does the number of internet searches for ways to prevent or limit the duration of viral illnesses. But, what is fact and what is fiction?

1 Feb 2013

Current recommendations for infection control among health care providers may not be adequate

Some people with the flu emit more of the air-borne virus than others, suggesting that the current recommendations for infection control among health care providers may not be adequate, according to a new study from researchers at Wake Forest Baptist Medical Center.

1 Feb 2013

Over half of countries struggling to prevent and manage cancer

More than half of all countries worldwide are struggling to prevent cancer and provide treatment and chronic care to cancer patients, warns a recent World Health Organization (WHO) survey for World Cancer Day. This means, currently many of these countries do not have a functional cancer control plan that includes prevention, early detection, treatment and care. There is an urgent need to help countries to reduce cancer deaths and provide appropriate long-term treatment and care to avoid human suffering and protect countries’ social and economic development.

1 Feb 2013

Moderate gum disease causes severe infection and inflammation in AIDS animal model

Texas Biomed scientists in San Antonio have found that moderate gum disease in an animal model exposed to an AIDS- like virus had more viral variants causing infection and greater inflammation. Both of these features have potential negative implications in long term disease progression, including other kinds of infections, the researchers say in a new report.

1 Feb 2013

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

Merck, known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2012.

1 Feb 2013

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Pfizer Inc. said today that the United States District Court for the District of Delaware ruled that Pfizer's patent covering a method for using sirolimus, the active ingredient in RAPAMUNE®, for the inhibition of organ transplant rejection is valid and infringed.

31 Jan 2013

Northeast Ohio Medical University, CEL-SCI produce new investigational breast cancer vaccine

CEL-SCI Corporation announced that its longstanding collaboration with Northeast Ohio Medical University has produced a new investigational breast cancer vaccine which prevents and treats a HER-2/neu expressing breast cancer tumor in a mouse model of the disease.

31 Jan 2013

Positive results from PaxVax's Ad4-H5-Vtn vector vaccine Phase 1 trial on avian flu

PaxVax, Inc., which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced positive results in a Phase 1 clinical trial for its oral, replicating adenovirus serotype 4 (Ad4) vector vaccine for H5N1 (avian flu).

31 Jan 2013

Interferon retreatment of chronic hepatitis C may be harmful

People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment. In fact, they may face an increased risk of dying sooner, and are likely to experience a variety of adverse effects, according to an updated systematic review published in The Cochrane Library.

31 Jan 2013

GSU associate professor receives federal grant to bolster flu vaccine research

Sang-Moo Kang, associate professor at Georgia State University's Center for Inflammation, Immunity and Infection, has received a federal five-year, $3.4 million grant to bolster research that will lead to better flu vaccines and vaccines against respiratory syncytial virus (RSV), a disease for which there is no immunization.

31 Jan 2013

Government mistrust and conspiracy fears deter older adults from getting tested for HIV

One out of every four people living with HIV/AIDS is 50 or older, yet these older individuals are far more likely to be diagnosed when they are already in the later stages of infection. Such late diagnoses put their health, and the health of others, at greater risk than would have been the case with earlier detection.

31 Jan 2013

Genentech announces positive results from GA101 plus chlorambucil Phase III study on CLL

Genentech, a member of the Roche Group, today announced positive results from Stage 1 of CLL11, a Phase III randomized study to investigate the efficacy and safety profile of the investigational medicine obinutuzumab (GA101) plus chlorambucil chemotherapy compared with chlorambucil alone in people with previously untreated chronic lymphocytic leukemia (CLL).

31 Jan 2013

Guidelines to help people with allergies during bad weather

As this winter continue to take many parts of the country on a temperature roller coaster ride—from seasonal bone-chilling cold to springlike warmth and then back again—many people find themselves reaching for pain relievers or other remedies to deal with runny noses and other symptoms associated with sinus and allergy problems.

31 Jan 2013

Sydney 2012 norovirus strain continues to spread globally

A new strain of norovirus known as Sydney 2012 has caused a significant number of acute outbreaks of the infection during the 2012–2013 winter season and continues to spread worldwide.

30 Jan 2013

New clue to why some people fight infections better than others

As influenza spreads through the northern hemisphere winter, Dr Linda Wakim and her colleagues in the Laboratory of Professor Jose Villadangos from the Department of Biochemistry and Molecular Biology, and the Department of Microbiology and Immunology, believe they have a new clue to why some people fight infections better than others.

30 Jan 2013

Low-income and minority parents/guardians receptive toward vaccinating boys against HPV

A new Boston University School of Medicine (BUSM) study has found that low-income and minority parents/guardians were receptive toward vaccinating boys against Human Papilloma Virus (HPV). However, racial/ethnic differences emerged in attitudes regarding school-entry mandates. The findings appear online in the journal Clinical Pediatrics.

30 Jan 2013

Have scientists thoroughly addressed avian flu research concerns?

Noting that a nearly yearlong moratorium on H5N1 avian influenza research, put in place "because of safety and terrorism concerns," was lifted recently, a New York Times editorial states, "We wish we could be as sanguine as they are that all the earlier concerns have been dealt with."

29 Jan 2013

New tweet-screening method effectively tracks flu cases

Sifting through social media messages has become a popular way to track when and where flu cases occur, but a key hurdle hampers the process: how to identify flu-infection tweets. Some tweets are posted by people who have been sick with the virus, while others come from folks who are merely talking about the illness. If you are tracking actual flu cases, such conversations about the flu in general can skew the results.

29 Jan 2013

Oncolytics Biotech reports new findings at ASCO’s 2013 Gastrointestinal Cancers Symposium

What did Pope John Paul II, Ronald Reagan and Robin Gibb of the Bee Gees have in common? Each was diagnosed with colorectal cancer, the third most commonly diagnosed cancer in the world and the fourth most common cause of cancer death.

29 Jan 2013

Common myths about flu from Mayo Clinic

It seems you can't go anywhere these days without hearing "the flu this" or "the flu that." Unfortunately, this season's influenza outbreak is one of the worst in years. And it's not just the flu virus that's causing problems; there are also many myths about the flu that are keeping people from doing more to prevent it.

29 Jan 2013

Virus News and Research

Latest Virus News and Research

Ten common notions concerning colds and flu

Current recommendations for infection control among health care providers may not be adequate

Over half of countries struggling to prevent and manage cancer

Moderate gum disease causes severe infection and inflammation in AIDS animal model

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Northeast Ohio Medical University, CEL-SCI produce new investigational breast cancer vaccine

Positive results from PaxVax's Ad4-H5-Vtn vector vaccine Phase 1 trial on avian flu

Interferon retreatment of chronic hepatitis C may be harmful

GSU associate professor receives federal grant to bolster flu vaccine research

Government mistrust and conspiracy fears deter older adults from getting tested for HIV

Genentech announces positive results from GA101 plus chlorambucil Phase III study on CLL

Guidelines to help people with allergies during bad weather

Sydney 2012 norovirus strain continues to spread globally

New clue to why some people fight infections better than others

Low-income and minority parents/guardians receptive toward vaccinating boys against HPV

Have scientists thoroughly addressed avian flu research concerns?

New tweet-screening method effectively tracks flu cases

Oncolytics Biotech reports new findings at ASCO’s 2013 Gastrointestinal Cancers Symposium

Common myths about flu from Mayo Clinic

A new way of characterising biomolecules eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in